Analyst Ratings for Cardiol Therapeutics (CRDL)
CRDL Rating Summary
CRDL Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.50 (+673.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$7.50 (+673.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2025 | Brookline Capital Markets | Tyler Bussian | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.08 (0.97) |
-10.19% | Details |
| 6/2/2025 | H.C. Wainwright » Updated 12/2/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.25 (0.97) |
-22.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
